{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T23:33:30Z","timestamp":1789774410367,"version":"4.0.1"},"reference-count":150,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T00:00:00Z","timestamp":1578355200000},"content-version":"vor","delay-in-days":2442,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1093\/annonc\/mds635","type":"journal-article","created":{"date-parts":[[2013,1,5]],"date-time":"2013-01-05T03:15:47Z","timestamp":1357355747000},"page":"1179-1189","source":"Crossref","is-referenced-by-count":74,"title":["Penile cancer: current therapy and future directions"],"prefix":"10.1016","volume":"24","author":[{"given":"G.","family":"Sonpavde","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.C.","family":"Pagliaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Buonerba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.B.","family":"Dorff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.J.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Di Lorenzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mds635_bb0010","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3322\/caac.20138","article-title":"Cancer statistics, 2012","volume":"62","author":"Siegel","year":"2012","journal-title":"CA Cancer J Clin"},{"key":"10.1093\/annonc\/mds635_bb0015","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.urolonc.2006.08.029","article-title":"Incidence trends in primary malignant penile cancer","volume":"25","author":"Barnholtz-Sloan","year":"2007","journal-title":"Urol Oncol"},{"key":"10.1093\/annonc\/mds635_bb0020","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/jso.20893","article-title":"Management of penile cancer","volume":"97","author":"Ornellas","year":"2008","journal-title":"J Surg Oncol"},{"key":"10.1093\/annonc\/mds635_bb0025","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S1470-2045(04)01427-5","article-title":"Penile carcinoma: a challenge for the developing world","volume":"5","author":"Misra","year":"2004","journal-title":"Lancet Oncol"},{"key":"10.1093\/annonc\/mds635_bb0030","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1158\/1055-9965.EPI-07-0221","article-title":"Demographic and pathologic differences in the incidence of invasive penile cancer in the United States, 1995\u20132003","volume":"16","author":"Goodman","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1093\/annonc\/mds635_bb0035","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1002\/cncr.23743","article-title":"Burden of invasive squamous cell carcinoma of the penis in the United States, 1998\u20132003","volume":"113","author":"Hernandez","year":"2008","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mds635_bb0040","doi-asserted-by":"crossref","first-page":"306","DOI":"10.3322\/canjclin.41.5.306","article-title":"The relationship between circumcision and cancer of the penis","volume":"41","author":"Schoen","year":"1991","journal-title":"CA Cancer J Clin"},{"key":"10.1093\/annonc\/mds635_bb0045","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1001\/archpedi.1980.02130170034012","article-title":"Circumcision and the risk of cancer of the penis. A life-table analysis","volume":"134","author":"Kochen","year":"1980","journal-title":"Am J Dis Child"},{"key":"10.1093\/annonc\/mds635_bb0050","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/00365590050509913","article-title":"Etiology of squamous cell carcinoma of the penis","author":"Dillner","year":"2000","journal-title":"Scand J Urol Nephrol Suppl"},{"key":"10.1093\/annonc\/mds635_bb0055","doi-asserted-by":"crossref","unstructured":"D Clouston A Hall N Lawrentschuk. Penile lichen sclerosus (balanitis xerotica obliterans)BJU Int108Suppl 21419","DOI":"10.1111\/j.1464-410X.2011.10699.x"},{"key":"10.1093\/annonc\/mds635_bb0060","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/bjc.1971.4","article-title":"Geographical variation of carcinoma of the penis in Uganda","volume":"25","author":"Schmauz","year":"1971","journal-title":"Br J Cancer"},{"key":"10.1093\/annonc\/mds635_bb0065","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/jnci\/85.1.19","article-title":"History of circumcision, medical conditions, and sexual activity and risk of penile cancer","volume":"85","author":"Maden","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"10.1093\/annonc\/mds635_bb0070","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1111\/j.1468-3083.2006.01653.x","article-title":"The carcinogenicity of smegma: debunking a myth","volume":"20","author":"Van Howe","year":"2006","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1093\/annonc\/mds635_bb0075","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1468-3083.2007.02439.x","article-title":"Re: \u2018RS Van Howe, FM Hodges. The carcinogenicity of smegma: debunking a myth.\u2019 An example of myth and mythchief making?","volume":"22","author":"Waskett","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1093\/annonc\/mds635_bb0080","doi-asserted-by":"crossref","first-page":"4550","DOI":"10.1200\/JCO.2007.12.3182","article-title":"Human papillomavirus-16 is the predominant type etiologically involved in penile squamous cell carcinoma","volume":"25","author":"Heideman","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mds635_bb0085","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00345-008-0302-z","article-title":"Penile cancer: epidemiology, pathogenesis and prevention","volume":"27","author":"Bleeker","year":"2009","journal-title":"World J Urol"},{"key":"10.1093\/annonc\/mds635_bb0090","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1002\/1097-0142(20010615)91:12<2315::AID-CNCR1263>3.0.CO;2-C","article-title":"Human papillomavirus as a prognostic factor in carcinoma of the penis: analysis of 82 patients treated with amputation and bilateral lymphadenectomy","volume":"91","author":"Bezerra","year":"2001","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mds635_bb0095","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s10552-008-9276-9","article-title":"Systematic review of human papillomavirus prevalence in invasive penile cancer","volume":"20","author":"Backes","year":"2009","journal-title":"Cancer Causes Control"},{"key":"10.1093\/annonc\/mds635_bb0100","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1093\/jnci\/87.22.1705","article-title":"Preferential association of human papillomavirus with high-grade histologic variants of penile-invasive squamous cell carcinoma","volume":"87","author":"Gregoire","year":"1995","journal-title":"J Natl Cancer Inst"},{"key":"10.1093\/annonc\/mds635_bb0105","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1136\/jcp.2008.063149","article-title":"Human papillomavirus prevalence and type distribution in penile carcinoma","volume":"62","author":"Miralles-Guri","year":"2009","journal-title":"J Clin Pathol"},{"key":"10.1093\/annonc\/mds635_bb0110","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/S0002-9440(10)62506-0","article-title":"Detection and typing of human papillomavirus DNA in penile carcinoma: evidence for multiple independent pathways of penile carcinogenesis","volume":"159","author":"Rubin","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1093\/annonc\/mds635_bb0115","unstructured":"S Mannweiler S Sygulla C Beham-Schmid. Penile carcinogenesis in a low-incidence area: a clinicopathologic and molecular analysis of 115 invasive carcinomas with special emphasis on chronic inflammatory skin diseasesAm J Surg Pathol359981006"},{"key":"10.1093\/annonc\/mds635_bb0120","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1056\/NEJMoa011688","article-title":"Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners","volume":"346","author":"Castellsague","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mds635_bb0125","doi-asserted-by":"crossref","unstructured":"DM Backes MC Bleeker CJ Meijer. Male circumcision is associated with a lower prevalence of human papillomavirus-associated penile lesions among Kenyan menInt J Cancer. 130: 1888-1897.","DOI":"10.1002\/ijc.26196"},{"key":"10.1093\/annonc\/mds635_bb0130","doi-asserted-by":"crossref","unstructured":"LF Barroso II T Wilkin. Human papillomavirus vaccination in males: the state of the scienceCurr Infect Dis Rep 13: 175-181.","DOI":"10.1007\/s11908-010-0163-7"},{"key":"10.1093\/annonc\/mds635_bb0135","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1097\/01.aids.0000238411.75324.59","article-title":"Trends in cancer risk among people with AIDS in the United States 1980\u20132002","volume":"20","author":"Engels","year":"2006","journal-title":"AIDS"},{"key":"10.1093\/annonc\/mds635_bb0140","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/ijc.21009","article-title":"Penile cancer: importance of circumcision, human papillomavirus and smoking in in situ and invasive disease","volume":"116","author":"Daling","year":"2005","journal-title":"Int J Cancer"},{"key":"10.1093\/annonc\/mds635_bb0145","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1136\/bmj.295.6609.1306","article-title":"Penile cancer: is there an epidemiological role for smoking and sexual behaviour?","volume":"295","author":"Hellberg","year":"1987","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1093\/annonc\/mds635_bb0150","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1056\/NEJM199004193221601","article-title":"Genital tumors among men with psoriasis exposed to psoralens and ultraviolet A radiation (PUVA) and ultraviolet B radiation. The Photochemotherapy Follow-up Study","volume":"322","author":"Stern","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mds635_bb0155","doi-asserted-by":"crossref","unstructured":"CF Heyns A Mendoza-Valdes AC Pompeo. Diagnosis and staging of penile cancer. Urology 76: S15-23.","DOI":"10.1016\/j.urology.2010.03.002"},{"key":"10.1093\/annonc\/mds635_bb0160","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0094-0143(21)00387-6","article-title":"Penile cancer. Clinical presentation, diagnosis, and staging","volume":"19","author":"Burgers","year":"1992","journal-title":"Urol Clin North Am"},{"key":"10.1093\/annonc\/mds635_bb0165","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/j.1464-410X.2006.06296.x","article-title":"A prospective study of 100 cases of penile cancer managed according to European Association of Urology guidelines","volume":"98","author":"Hegarty","year":"2006","journal-title":"BJU Int"},{"key":"10.1093\/annonc\/mds635_bb0170","doi-asserted-by":"crossref","unstructured":"B Schlenker B Scher R Tiling. Detection of inguinal lymph node involvement in penile squamous cell carcinoma by 18F-fluorodeoxyglucose PET\/CT: a prospective single-center study. Urol Oncol 30: 55-59.","DOI":"10.1016\/j.urolonc.2009.10.012"},{"key":"10.1093\/annonc\/mds635_bb0175","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.eururo.2009.05.016","article-title":"Scanning with 18F-FDG-PET\/CT for detection of pelvic nodal involvement in inguinal node-positive penile carcinoma","volume":"56","author":"Graafland","year":"2009","journal-title":"Eur Urol"},{"key":"10.1093\/annonc\/mds635_bb0180","doi-asserted-by":"crossref","unstructured":"I Souillac J Rigaud C Ansquer. Prospective evaluation of (18)F-fluorodeoxyglucose positron emission tomography-computerized tomography to assess inguinal lymph node status in invasive squamous cell carcinoma of the penis. J Urol 187:493-497.","DOI":"10.1016\/j.juro.2011.10.033"},{"key":"10.1093\/annonc\/mds635_bb0185","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.urolonc.2010.09.015","article-title":"Utility of (18)F-FDG PET\/CT in identifying penile squamous cell carcinoma metastatic lymph nodes","volume":"30","author":"Rosevear","year":"2012","journal-title":"Urol Oncol"},{"key":"10.1093\/annonc\/mds635_bb0190","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1111\/j.1464-410X.2009.08450.x","article-title":"Prospective evaluation of hybrid 18F-fluorodeoxyglucose positron emission tomography\/computed tomography in staging clinically node-negative patients with penile carcinoma","volume":"104","author":"Leijte","year":"2009","journal-title":"BJU Int"},{"key":"10.1093\/annonc\/mds635_bb0195","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.eururo.2006.11.014","article-title":"The role of magnetic resonance imaging in the local staging of penile cancer","volume":"51","author":"Kayes","year":"2007","journal-title":"Eur Urol"},{"key":"10.1093\/annonc\/mds635_bb0200","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1177\/106689690100900204","article-title":"Histologic classification of penile carcinoma and its relation to outcome in 61 patients with primary resection","volume":"9","author":"Cubilla","year":"2001","journal-title":"Int J Surg Pathol"},{"key":"10.1093\/annonc\/mds635_bb0205","series-title":"World Health Organization Classification of Tumours Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs,","first-page":"281","author":"Eble","year":"2004"},{"key":"10.1093\/annonc\/mds635_bb0210","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/S0022-5347(17)35222-9","article-title":"Surgical treatment of invasive squamous cell carcinoma of the penis: retrospective analysis of 350 cases","volume":"151","author":"Ornellas","year":"1994","journal-title":"J Urol"},{"key":"10.1093\/annonc\/mds635_bb0215","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/modpathol.2009.77","article-title":"HPV infection and immunochemical detection of cell-cycle markers in verrucous carcinoma of the penis","volume":"22","author":"Stankiewicz","year":"2009","journal-title":"Mod Pathol"},{"key":"10.1093\/annonc\/mds635_bb0220","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1002\/cncr.21078","article-title":"Paclitaxel, carboplatin, and gemcitabine in the treatment of patients with advanced transitional cell carcinoma of the urothelium","volume":"103","author":"Hainsworth","year":"2005","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mds635_bb0225","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.eururo.2010.01.039","article-title":"EAU penile cancer guidelines","volume":"57","author":"Pizzocaro","year":"2009","journal-title":"Eur Urol"},{"key":"10.1093\/annonc\/mds635_bb0230","doi-asserted-by":"crossref","unstructured":"AL Cubilla B Lloveras M Alejo. The basaloid cell is the best tissue marker for human papillomavirus in invasive penile squamous cell carcinoma: a study of 202 cases from Paraguay. Am J Surg Pathol 34:104-114.","DOI":"10.1097\/PAS.0b013e3181c76a49"},{"key":"10.1093\/annonc\/mds635_bb0235","doi-asserted-by":"crossref","unstructured":"AL Cubilla B Lloveras M Alejo. Value of p16(INK)(4)(a) in the pathology of invasive penile squamous cell carcinomas: a report of 202 cases. Am J Surg Pathol 35: 253-261.","DOI":"10.1097\/PAS.0b013e318203cdba"},{"key":"10.1093\/annonc\/mds635_bb0240","doi-asserted-by":"crossref","unstructured":"N Lavens R Gupta LA Wood. EGFR overexpression in squamous cell carcinoma of the penisCurr Oncol 17: 4-6.","DOI":"10.3747\/co.v17i1.471"},{"issue":"Suppl 7","key":"10.1093\/annonc\/mds635_bb0245","article-title":"EGFR, TS, and ERCC1 expression in penile squamous cancer","volume":"29","author":"Dorff","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mds635_bb0250","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S1470-2045(07)70137-7","article-title":"Molecular and genetic pathways in penile cancer","volume":"8","author":"Kayes","year":"2007","journal-title":"Lancet Oncol"},{"issue":"Suppl 7","key":"10.1093\/annonc\/mds635_bb0255","article-title":"BRAF and KRAS mutations in penile cancer and their correlation with clinical features","volume":"29","author":"Valverde","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mds635_bb0260","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1016\/j.juro.2007.12.040","article-title":"PIK3CA, HRAS and KRAS gene mutations in human penile cancer","volume":"179","author":"Andersson","year":"2008","journal-title":"J Urol"},{"key":"10.1093\/annonc\/mds635_bb0265","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/sj.bjc.6601894","article-title":"The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website","volume":"91","author":"Bamford","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1093\/annonc\/mds635_bb0270","doi-asserted-by":"crossref","unstructured":"E Stankiewicz DM Prowse M Ng. Alternative HER\/PTEN\/Akt pathway activation in HPV positive and negative penile carcinomas. PLoS One 6:e17517.","DOI":"10.1371\/journal.pone.0017517"},{"key":"10.1093\/annonc\/mds635_bb0275","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/j.1464-410X.2008.07603.x","article-title":"Hypermethylation of the thrombospondin-1 gene is associated with poor prognosis in penile squamous cell carcinoma","volume":"102","author":"Guerrero","year":"2008","journal-title":"BJU Int"},{"key":"10.1093\/annonc\/mds635_bb0280","doi-asserted-by":"crossref","unstructured":"M Poetsch M Hemmerich C Kakies. Alterations in the tumor suppressor gene p16(INK4A) are associated with aggressive behavior of penile carcinomas. Virchows Arch 458:221-229.","DOI":"10.1007\/s00428-010-1007-4"},{"key":"10.1093\/annonc\/mds635_bb0285","doi-asserted-by":"crossref","unstructured":"E Stankiewicz DM Prowse E Ktori. The retinoblastoma protein\/p16 INK4A pathway but not p53 is disrupted by human papillomavirus in penile squamous cell carcinoma. Histopathology 58: 433-439.","DOI":"10.1111\/j.1365-2559.2011.03762.x"},{"key":"10.1093\/annonc\/mds635_bb0290","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0022-5347(05)64836-7","article-title":"p53 as a new prognostic factor for lymph node metastasis in penile carcinoma: analysis of 82 patients treated with amputation and bilateral lymphadenectomy","volume":"168","author":"Lopes","year":"2002","journal-title":"J Urol"},{"key":"10.1093\/annonc\/mds635_bb0295","doi-asserted-by":"crossref","unstructured":"S Gunia C Kakies A Erbersdobler. Expression of p53, p21 and cyclin D1 in penile cancer: p53 predicts poor prognosis. J Clin Pathol 65: 232-236.","DOI":"10.1136\/jclinpath-2011-200429"},{"key":"10.1093\/annonc\/mds635_bb0300","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1464-410X.2007.06908.x","article-title":"The prognostic significance of p53, Ki-67, epithelial cadherin and matrix metalloproteinase-9 in penile squamous cell carcinoma treated with surgery","volume":"100","author":"Zhu","year":"2007","journal-title":"BJU Int"},{"key":"10.1093\/annonc\/mds635_bb0305","doi-asserted-by":"crossref","first-page":"7335","DOI":"10.1158\/1078-0432.CCR-09-0882","article-title":"DNA replication licensing factors and aneuploidy are linked to tumor cell cycle state and clinical outcome in penile carcinoma","volume":"15","author":"Kayes","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1093\/annonc\/mds635_bb0310","first-page":"67","article-title":"Determination of telomerase activity in squamous cell carcinoma of the penis","volume":"18","author":"Alves","year":"2001","journal-title":"Int J Oncol"},{"key":"10.1093\/annonc\/mds635_bb0315","first-page":"353","article-title":"Bax and bcl-2 imbalance and HPB infection in penile tumors and adjacent tissues","volume":"14","author":"Nascimento Pde","year":"2004","journal-title":"Prog Urol"},{"key":"10.1093\/annonc\/mds635_bb0320","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/gcc.1117","article-title":"Genetic imbalances in 26 cases of penile squamous cell carcinoma","volume":"31","author":"Alves","year":"2001","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1093\/annonc\/mds635_bb0325","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1158\/1078-0432.CCR-1032-3","article-title":"Cyclooxygenase-2 and microsomal prostaglandin E synthase-1 are overexpressed in squamous cell carcinoma of the penis","volume":"10","author":"Golijanin","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1093\/annonc\/mds635_bb0330","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1159\/000315432","article-title":"Feasibility and activity of sorafenib and sunitinib in advanced penile cancer: a preliminary report","volume":"85","author":"Zhu","year":"2010","journal-title":"Urol Int"},{"key":"10.1093\/annonc\/mds635_bb0335","first-page":"239","article-title":"TNM Classification of Malignant Tumors. UICC International Union Against Cancer","author":"Sobin","year":"2009"},{"key":"10.1093\/annonc\/mds635_bb0340","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.juro.2010.06.016","article-title":"Prognostic significance of extranodal extension in patients with pathological node positive penile carcinoma","volume":"184","author":"Graafland","year":"2010","journal-title":"J Urol"},{"key":"10.1093\/annonc\/mds635_bb0345","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/S0022-5347(05)01003-7","article-title":"Nomogram predictive of pathological inguinal lymph node involvement in patients with squamous cell carcinoma of the penis","volume":"175","author":"Ficarra","year":"2006","journal-title":"J Urol"},{"key":"10.1093\/annonc\/mds635_bb0350","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1016\/S0022-5347(06)00313-2","article-title":"Nomogram predictive of cancer specific survival in patients undergoing partial or total amputation for squamous cell carcinoma of the penis","volume":"175","author":"Kattan","year":"2006","journal-title":"J Urol"},{"key":"10.1093\/annonc\/mds635_bb0355","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1158\/1078-0432.CCR-08-1888","article-title":"A simple and accurate model for prediction of cancer-specific mortality in patients treated with surgery for primary penile squamous cell carcinoma","volume":"15","author":"Zini","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1093\/annonc\/mds635_bb0360","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1002\/1097-0142(197311)32:5<1256::AID-CNCR2820320534>3.0.CO;2-G","article-title":"Proceedings: carcinoma of the penis","volume":"32","author":"de Kernion","year":"1973","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mds635_bb0365","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/j.juro.2008.06.028","article-title":"Prognostic factors in invasive squamous cell carcinoma of the penis: analysis of 196 patients treated at the Brazilian National Cancer Institute","volume":"180","author":"Ornellas","year":"2008","journal-title":"J Urol"},{"key":"10.1093\/annonc\/mds635_bb0370","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0360-3016(97)00068-0","article-title":"Treatment results and prognostic factors in 101 men treated for squamous carcinoma of the penis","volume":"38","author":"Sarin","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1093\/annonc\/mds635_bb0375","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1016\/j.urology.2010.04.008","article-title":"Prognostic factors in penile cancer","volume":"76","author":"Ficarra","year":"2010","journal-title":"Urology"},{"key":"10.1093\/annonc\/mds635_bb0380","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.eururo.2010.08.015","article-title":"Prognostic factors for occult inguinal lymph node involvement in penile carcinoma and assessment of the high-risk EAU subgroup: a two-institution analysis of 342 clinically node-negative patients","volume":"58","author":"Graafland","year":"2010","journal-title":"Eur Urol"},{"key":"10.1093\/annonc\/mds635_bb0385","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1016\/j.juro.2009.08.029","article-title":"Association between lymph node density and disease specific survival in patients with penile cancer","volume":"182","author":"Svatek","year":"2009","journal-title":"J Urol"},{"key":"10.1093\/annonc\/mds635_bb0390","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/S0022-5347(01)65471-5","article-title":"Prognostic factors in carcinoma of the penis: multivariate analysis of 145 patients treated with amputation and lymphadenectomy","volume":"156","author":"Lopes","year":"1996","journal-title":"J Urol"},{"key":"10.1093\/annonc\/mds635_bb0395","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.urology.2006.01.050","article-title":"Front pattern of invasion in squamous cell carcinoma of the penis: new prognostic factor for predicting risk of lymph node metastases","volume":"68","author":"Guimaraes","year":"2006","journal-title":"Urology"},{"key":"10.1093\/annonc\/mds635_bb0400","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/S0022-5347(05)66450-6","article-title":"Tumor stage, vascular invasion and the percentage of poorly differentiated cancer: independent prognosticators for inguinal lymph node metastasis in penile squamous cancer","volume":"165","author":"Slaton","year":"2001","journal-title":"J Urol"},{"key":"10.1093\/annonc\/mds635_bb0405","doi-asserted-by":"crossref","first-page":"3723","DOI":"10.1002\/cncr.25974","article-title":"Conditional survival predictions after surgery for patients with penile carcinoma","volume":"117","author":"Thuret","year":"2011","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mds635_bb0410","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.juro.2010.09.111","article-title":"Tumor grade improves the prognostic ability of American Joint Committee on Cancer stage in patients with penile carcinoma","volume":"185","author":"Thuret","year":"2011","journal-title":"J Urol"},{"key":"10.1093\/annonc\/mds635_bb0415","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1002\/cncr.21076","volume":"103","author":"Ficarra","year":"2005","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mds635_bb0420","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1023\/A:1008248319036","article-title":"Squamous cell carcinoma of the penis: multivariate analysis of prognostic factors and natural history in monocentric study with a conservative policy","volume":"8","author":"Soria","year":"1997","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mds635_bb0425","article-title":"Clear-cell differentiation and lymphatic invasion, but not the revised TNM classification, predict lymph node metastases in pT1 penile cancer: a clinicopathologic study of 76 patients from a low incidence area","author":"Mannweiler","year":"2012","journal-title":"Urol Oncol"},{"key":"10.1093\/annonc\/mds635_bb0430","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.urology.2005.10.026","article-title":"E-cadherin, MMP-2, and MMP-9 as prognostic markers in penile cancer: analysis of 125 patients","volume":"67","author":"Campos","year":"2006","journal-title":"Urology"},{"key":"10.1093\/annonc\/mds635_bb0435","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00428-008-0590-0","article-title":"Down-regulation of the metastasis suppressor protein KAI1\/CD82 correlates with occurrence of metastasis, prognosis and presence of HPV DNA in human penile squamous cell carcinoma","volume":"452","author":"Protzel","year":"2008","journal-title":"Virchows Arch"},{"key":"10.1093\/annonc\/mds635_bb0440","first-page":"1197","article-title":"Expression of proliferation marker Ki67 correlates to occurrence of metastasis and prognosis, histological subtypes and HPV DNA detection in penile carcinomas","volume":"22","author":"Protzel","year":"2007","journal-title":"Histol Histopathol"},{"key":"10.1093\/annonc\/mds635_bb0445","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00345-010-0575-x","article-title":"The role of annexins I, II and IV in tumor development, progression and metastasis of human penile squamous cell carcinomas","volume":"29","author":"Protzel","year":"2011","journal-title":"World J Urol"},{"key":"10.1093\/annonc\/mds635_bb0450","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1002\/ijc.21961","article-title":"Presence of high-risk human papillomavirus DNA in penile carcinoma predicts favorable outcome in survival","volume":"119","author":"Lont","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1093\/annonc\/mds635_bb0455","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.juro.2011.10.149","article-title":"p16(INK4a) is a marker of good prognosis for primary invasive penile squamous cell carcinoma: a multi-institutional study","volume":"187","author":"Gunia","year":"2012","journal-title":"J Urol"},{"key":"10.1093\/annonc\/mds635_bb0460","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/j.juro.2011.05.084","article-title":"Long-term outcome of excisional organ sparing surgery for carcinoma of the penis","volume":"186","author":"Feldman","year":"2011","journal-title":"J Urol"},{"key":"10.1093\/annonc\/mds635_bb0465","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1111\/j.1464-410X.2005.05769.x","article-title":"What surgical resection margins are required to achieve oncological control in men with primary penile cancer?","volume":"96","author":"Minhas","year":"2005","journal-title":"BJU Int"},{"key":"10.1093\/annonc\/mds635_bb0470","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1016\/j.juro.2010.02.025","article-title":"Long-term followup of penile carcinoma with high risk for lymph node invasion treated with inguinal lymphadenectomy","volume":"183","author":"Marconnet","year":"2010","journal-title":"J Urol"},{"key":"10.1093\/annonc\/mds635_bb0475","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.eururo.2009.02.021","article-title":"Lymphadenectomy in the surgical management of penile cancer","volume":"55","author":"Protzel","year":"2009","journal-title":"Eur Urol"},{"key":"10.1093\/annonc\/mds635_bb0480","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/j.urology.2010.03.001","article-title":"Management of the lymph nodes in penile cancer","volume":"76","author":"Heyns","year":"2010","journal-title":"Urology"},{"issue":"Suppl 1","key":"10.1093\/annonc\/mds635_bb0485","first-page":"30","article-title":"Extended lymphadenectomy in penile cancer","volume":"12","author":"Pompeo","year":"2005","journal-title":"Can J Urol"},{"key":"10.1093\/annonc\/mds635_bb0490","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1097\/01.ju.0000154565.37397.4d","article-title":"Patients with penile carcinoma benefit from immediate resection of clinically occult lymph node metastases","volume":"173","author":"Kroon","year":"2005","journal-title":"J Urol"},{"key":"10.1093\/annonc\/mds635_bb0495","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.juro.2006.10.060","article-title":"Pelvic lymph node dissection for penile carcinoma: extent of inguinal lymph node involvement as an indicator for pelvic lymph node involvement and survival","volume":"177","author":"Lont","year":"2007","journal-title":"J Urol"},{"key":"10.1093\/annonc\/mds635_bb0500","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/jso.20980","article-title":"Surgical treatment of invasive squamous cell carcinoma of the penis: Brazilian National Cancer Institute long-term experience","volume":"97","author":"Ornellas","year":"2008","journal-title":"J Surg Oncol"},{"key":"10.1093\/annonc\/mds635_bb0505","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1016\/j.juro.2007.01.125","article-title":"Preoperative lymphoscintigraphy and dynamic sentinel node biopsy for staging penile cancer: results with pathological correlation","volume":"177","author":"Spiess","year":"2007","journal-title":"J Urol"},{"issue":"Suppl 1","key":"10.1093\/annonc\/mds635_bb0510","first-page":"24","article-title":"Sentinel lymph node biopsy in penile cancer: evolution and insights","volume":"12","author":"Izawa","year":"2005","journal-title":"Can J Urol"},{"key":"10.1093\/annonc\/mds635_bb0515","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s00345-006-0073-3","article-title":"Lymphoscintigraphy in penile cancer: limited value of sentinel node biopsy in patients with clinically suspicious lymph nodes","volume":"24","author":"Hungerhuber","year":"2006","journal-title":"World J Urol"},{"key":"10.1093\/annonc\/mds635_bb0520","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1245\/s10434-010-1546-6","article-title":"Dynamic sentinel node biopsy for inguinal lymph node staging in patients with penile cancer: a systematic review and cumulative analysis of the literature","volume":"18","author":"Neto","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"10.1093\/annonc\/mds635_bb0525","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.eururo.2010.06.036","article-title":"Nodal staging in penile carcinoma by dynamic sentinel node biopsy after previous therapeutic primary tumour resection","volume":"58","author":"Graafland","year":"2010","journal-title":"Eur Urol"},{"key":"10.1093\/annonc\/mds635_bb0530","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1016\/S0022-5347(01)66671-0","article-title":"Sentinel lymph node dissection for penile carcinoma: the M. D. Anderson Cancer Center experience","volume":"154","author":"Pettaway","year":"1995","journal-title":"J Urol"},{"key":"10.1093\/annonc\/mds635_bb0535","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.juro.2006.10.075","article-title":"Video endoscopic inguinal lymphadenectomy: a new minimally invasive procedure for radical management of inguinal nodes in patients with penile squamous cell carcinoma","volume":"177","author":"Tobias-Machado","year":"2007","journal-title":"J Urol"},{"key":"10.1093\/annonc\/mds635_bb0540","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.eururo.2008.04.016","article-title":"Recurrence patterns of squamous cell carcinoma of the penis: recommendations for follow-up based on a two-centre analysis of 700 patients","volume":"54","author":"Leijte","year":"2008","journal-title":"Eur Urol"},{"key":"10.1093\/annonc\/mds635_bb0545","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.juro.2011.03.117","article-title":"Radiotherapy for node positive penile cancer: experience of the Leeds teaching hospitals","volume":"186","author":"Franks","year":"2011","journal-title":"J Urol"},{"key":"10.1093\/annonc\/mds635_bb0550","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s00345-003-0383-7","article-title":"Contemporary management of penile cancer including surgery and adjuvant radiotherapy: an experience in Taiwan","volume":"22","author":"Chen","year":"2004","journal-title":"World J Urol"},{"key":"10.1093\/annonc\/mds635_bb0555","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1111\/j.1464-410X.2007.07168.x","article-title":"A 10-year retrospective audit of penile cancer management in the UK","volume":"100","author":"Mistry","year":"2007","journal-title":"BJU Int"},{"key":"10.1093\/annonc\/mds635_bb0560","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1159\/000020298","article-title":"Is conservative organ-sparing treatment of penile carcinoma justified?","volume":"38","author":"Gotsadze","year":"2000","journal-title":"Eur Urol"},{"key":"10.1093\/annonc\/mds635_bb0565","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.clon.2006.01.004","article-title":"External-beam radiotherapy in T1-2 N0 penile carcinoma","volume":"18","author":"Azrif","year":"2006","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1093\/annonc\/mds635_bb0570","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S0959-8049(00)00368-3","article-title":"Radiation therapy alone or combined surgery and radiation therapy in squamous-cell carcinoma of the penis?","volume":"37","author":"Zouhair","year":"2001","journal-title":"Eur J Cancer"},{"key":"10.1093\/annonc\/mds635_bb0575","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0167-8140(95)01574-Z","article-title":"Interstitial brachytherapy for penile carcinoma: a multicentric survey (259 patients)","volume":"36","author":"Rozan","year":"1995","journal-title":"Radiother Oncol"},{"key":"10.1093\/annonc\/mds635_bb0580","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/j.ijrobp.2008.09.054","article-title":"Long-term results of brachytherapy for carcinoma of the penis confined to the glans (N- or NX)","volume":"74","author":"de Crevoisier","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1093\/annonc\/mds635_bb0585","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/S0022-5347(01)69074-8","article-title":"Interstitial brachytherapy for penile cancer: an alternative to amputation","volume":"167","author":"Crook","year":"2002","journal-title":"J Urol"},{"key":"10.1093\/annonc\/mds635_bb0590","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/00000421-199312000-00009","article-title":"Combined modality therapy for locally advanced penile squamous cell carcinoma","volume":"16","author":"Pedrick","year":"1993","journal-title":"Am J Clin Oncol"},{"key":"10.1093\/annonc\/mds635_bb0595","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1001\/archdermatol.2009.160","article-title":"Primary treatment of verrucous carcinoma of the penis with fluorouracil, cis-diamino-dichloro-platinum, and radiation therapy","volume":"145","author":"Eliason","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1093\/annonc\/mds635_bb0600","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0140-6736(96)03409-5","article-title":"Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Committee on Cancer Research","volume":"348","year":"1996","journal-title":"Lancet"},{"key":"10.1093\/annonc\/mds635_bb0605","first-page":"CD003752","article-title":"Neoadjuvant chemoradiation for advanced primary vulvar cancer","volume":"19","author":"van Doorn","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1093\/annonc\/mds635_bb0610","doi-asserted-by":"crossref","first-page":"823","DOI":"10.3109\/02841868809094366","article-title":"Adjuvant and neoadjuvant vincristine, bleomycin, and methotrexate for inguinal metastases from squamous cell carcinoma of the penis","volume":"27","author":"Pizzocaro","year":"1988","journal-title":"Acta Oncol"},{"key":"10.1093\/annonc\/mds635_bb0615","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.eururo.2007.02.006","article-title":"Neoadjuvant chemotherapy in advanced penile carcinoma","volume":"52","author":"Leijte","year":"2007","journal-title":"Eur Urol"},{"key":"10.1093\/annonc\/mds635_bb0620","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1111\/j.1464-410X.2006.06496.x","article-title":"Cisplatin, methotrexate and bleomycin for treating advanced penile carcinoma","volume":"98","author":"Hakenberg","year":"2006","journal-title":"BJU Int"},{"key":"10.1093\/annonc\/mds635_bb0625","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.juro.2006.11.038","article-title":"Neoadjuvant chemotherapy followed by aggressive surgical consolidation for metastatic penile squamous cell carcinoma","volume":"177","author":"Bermejo","year":"2007","journal-title":"J Urol"},{"key":"10.1093\/annonc\/mds635_bb0630","doi-asserted-by":"crossref","first-page":"3851","DOI":"10.1200\/JCO.2010.29.5477","article-title":"Neoadjuvant paclitaxel, ifosfamide, and cisplatin chemotherapy for metastatic penile cancer: a phase II study","volume":"28","author":"Pagliaro","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mds635_bb0635","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1007\/s00259-010-1434-0","article-title":"18F-FDG PET\/CT for monitoring induction chemotherapy in patients with primary inoperable penile carcinoma: first clinical results","volume":"37","author":"Graafland","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1093\/annonc\/mds635_bb0640","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/j.1464-410X.1983.tb03366.x","article-title":"Adjuvant treatment using bleomycin in squamous cell carcinoma of penis: study of 19 cases","volume":"55","author":"Maiche","year":"1983","journal-title":"Br J Urol"},{"key":"10.1093\/annonc\/mds635_bb0645","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1007\/s00120-009-2108-z","article-title":"The current state of the art of chemotherapy of penile cancer: results of a nationwide survey of German clinics","volume":"48","author":"Protzel","year":"2009","journal-title":"Urologe A"},{"key":"10.1093\/annonc\/mds635_bb0650","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0022-5347(17)40590-8","article-title":"cis-Diamminedichloroplatinum in the treatment of advanced epidermoid carcinoma of the penis: a Southwest Oncology Group Study","volume":"141","author":"Gagliano","year":"1989","journal-title":"J Urol"},{"key":"10.1093\/annonc\/mds635_bb0655","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1016\/S0022-5347(01)62402-9","article-title":"Combination chemotherapy for metastatic or locally advanced genitourinary squamous cell carcinoma: a phase II study of methotrexate, cisplatin and bleomycin","volume":"160","author":"Corral","year":"1998","journal-title":"J Urol"},{"key":"10.1093\/annonc\/mds635_bb0660","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/S0022-5347(17)38069-2","article-title":"Combination chemotherapy with methotrexate, bleomycin and cisplatin for advanced squamous cell carcinoma of the male genital tract","volume":"146","author":"Dexeus","year":"1991","journal-title":"J Urol"},{"key":"10.1093\/annonc\/mds635_bb0665","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1016\/S0022-5347(05)68815-5","article-title":"Cisplatin, methotrexate and bleomycin for the treatment of carcinoma of the penis: a Southwest Oncology Group study","volume":"161","author":"Haas","year":"1999","journal-title":"J Urol"},{"key":"10.1093\/annonc\/mds635_bb0670","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1016\/j.urology.2010.03.082","article-title":"Treatment of visceral, unresectable, or bulky\/unresectable regional metastases of penile cancer","volume":"76","author":"Pettaway","year":"2010","journal-title":"Urology"},{"key":"10.1093\/annonc\/mds635_bb0675","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.eururo.2008.07.014","article-title":"Taxanes in combination with cisplatin and fluorouracil for advanced penile cancer: preliminary results","volume":"55","author":"Pizzocaro","year":"2009","journal-title":"Eur Urol"},{"key":"10.1093\/annonc\/mds635_bb0680","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.ucl.2010.04.010","article-title":"Chemotherapy for penile and urethral carcinoma","volume":"37","author":"Trabulsi","year":"2010","journal-title":"Urol Clin North Am"},{"key":"10.1093\/annonc\/mds635_bb0685","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/1097-0142(19900201)65:3<433::AID-CNCR2820650310>3.0.CO;2-G","article-title":"Chemotherapy with cisplatin and 5-fluorouracil for penile and urethral squamous cell carcinomas","volume":"65","author":"Hussein","year":"1990","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mds635_bb0690","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S0022-5347(17)37327-5","article-title":"Cisplatin and 5-fluorouracil in advanced cancer of the penis","volume":"147","author":"Shammas","year":"1992","journal-title":"J Urol"},{"key":"10.1093\/annonc\/mds635_bb0695","doi-asserted-by":"crossref","DOI":"10.1111\/j.1464-410X.2012.11453.x","article-title":"Cisplatin and 5-fluorouracil in inoperable, stage IV squamous cell carcinoma of the penis","author":"Di Lorenzo","year":"2012","journal-title":"BJU Int"},{"issue":"Suppl 8","key":"10.1093\/annonc\/mds635_bb0700","first-page":"viii271","article-title":"A combination of cisplatin and 5-fluorouracil plus a taxane for advanced squamous-cell carcinoma (SCC) of the penis: a single institution series","volume":"21","author":"Necchi","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mds635_bb0705","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1093\/annonc\/mdn149","article-title":"A phase II multicentre study of irinotecan (CPT 11) in combination with cisplatin (CDDP) in metastatic or locally advanced penile carcinoma (EORTC PROTOCOL 30992)","volume":"19","author":"Theodore","year":"2008","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mds635_bb0710","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.urolonc.2007.10.015","article-title":"Cisplatin and gemcitabine in the management of metastatic penile cancer","volume":"27","author":"Power","year":"2009","journal-title":"Urol Oncol"},{"key":"10.1093\/annonc\/mds635_bb0715","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/j.eururo.2011.08.028","article-title":"Paclitaxel in pretreated metastatic penile cancer: final results of a phase 2 study","volume":"60","author":"Di Lorenzo","year":"2011","journal-title":"Eur Urol"},{"issue":"Suppl","key":"10.1093\/annonc\/mds635_bb0720","article-title":"Epidermal growth factor receptor (EGFR) targeted therapy in advanced metastatic squamous cell carcinoma (AMSCC) of the penis: updates and molecular analyses","volume":"28","author":"Carthon","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mds635_bb0725","doi-asserted-by":"crossref","first-page":"e650","DOI":"10.1200\/JCO.2011.34.8367","article-title":"Proof of activity of anti-epidermal growth factor receptor-targeted therapy for relapsed squamous cell carcinoma of the penis","volume":"29","author":"Necchi","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mds635_bb0730","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1097\/CAD.0b013e328350ead7","article-title":"Combination of docetaxel and cetuximab for penile cancer: a case report and literature review","volume":"23","author":"Rescigno","year":"2012","journal-title":"Anticancer Drugs"},{"key":"10.1093\/annonc\/mds635_bb0735","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1200\/JCO.2011.38.6979","article-title":"Randomized phase III study comparing paclitaxel\/cisplatin\/gemcitabine and gemcitabine\/cisplatin in patients with locally advanced or metastatic urothelial cancer without prior systemic therapy: EORTC Intergroup Study 30987","volume":"30","author":"Bellmunt","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mds635_bb0740","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mds635_bb0745","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0140-6736(10)61121-X","article-title":"Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial","volume":"376","author":"Bang","year":"2010","journal-title":"Lancet"},{"key":"10.1093\/annonc\/mds635_bb0750","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1136\/sti.2009.036061","article-title":"Referrals into a dedicated British penile cancer centre and sources of possible delay","volume":"85","author":"Lucky","year":"2009","journal-title":"Sex Transm Infect"},{"key":"10.1093\/annonc\/mds635_bb0755","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1158\/1078-0432.CCR-09-1961","article-title":"Approaches to phase 1 clinical trial design focused on safety, efficiency, and selected patient populations: a report from the clinical trial design task force of the national cancer institute investigational drug steering committee","volume":"16","author":"Ivy","year":"2010","journal-title":"Clin Cancer Res"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419372540?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419372540?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/24\/5\/1179\/573064\/mds635.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,26]],"date-time":"2021-06-26T07:47:21Z","timestamp":1624693641000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419372540"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":150,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S0923753419372540"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mds635","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]}}}